Steven Cohen Dr Reddys Laboratories LTD Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$64.27 - $69.9 $154,248 - $167,760	2,400 New	2,400 $166,000
Q4 2019 Feb 14, 2020	SELL	$36.66 - $41.78 $286,681 - $326,719	-7,820 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$34.82 - $39.26 $272,292 - $307,013	7,820 New	7,820 $296,000
Q1 2019 May 15, 2019	SELL	$35.77 - $40.57 $599,147 - $679,547	-16,750 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$31.89 - $38.44 $534,157 - $643,870	16,750 New	16,750 $631,000

265

107M

71K

22.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.28B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.